Bioventus (BVS) News Today → The only financial event in 2024 that matters (From Porter & Company) (Ad) Free BVS Stock Alerts $6.69 -0.09 (-1.33%) (As of 05/31/2024 ET) Add Compare Share Share HeadlinesStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsTrendsStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsTrends All Sources Trusted Sources MarketBeat.com Benzinga Bloomberg MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha The Street The Wall Street Journal Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative May 28, 2024 | marketbeat.comBioventus (NYSE:BVS) Hits New 1-Year High at $6.87Bioventus (NYSE:BVS) Reaches New 12-Month High at $6.87May 23, 2024 | investorplace.com3 Stocks Under $10 With Mammoth Growth ProspectsMay 20, 2024 | marketbeat.comBioventus (NYSE:BVS) Shares Gap Down to $6.38Bioventus (NYSE:BVS) Shares Gap Down to $6.38May 16, 2024 | marketbeat.comBioventus (NYSE:BVS) Shares Up 4.4%Bioventus (NYSE:BVS) Trading 4.4% HigherMay 8, 2024 | finance.yahoo.comBioventus Inc. (NASDAQ:BVS) Q1 2024 Earnings Call TranscriptMay 8, 2024 | marketbeat.comBioventus (NYSE:BVS) Releases FY 2024 Earnings GuidanceBioventus (NYSE:BVS) updated its FY 2024 earnings guidance. The company provided EPS guidance of 0.250-0.330 for the period, compared to the consensus estimate of 0.160. The company also issued revenue guidance of $535.0 millionillion-$550.0 millionillion, compared to the consensus estimate of $528.0 millionillion.May 8, 2024 | bizjournals.comDurham public company reports earnings boost after CEO shakeupMay 8, 2024 | finance.yahoo.comBioventus Inc (BVS) Q1 2024 Earnings Call Transcript Highlights: Strong Start with Significant ...May 7, 2024 | marketwatch.comBioventus Shares Rise 23% After Narrower-Than-Expected 1Q LossMay 7, 2024 | msn.comBVS Stock Earnings: Bioventus Beats EPS, Beats Revenue for Q1 2024May 7, 2024 | globenewswire.comBioventus Reports First Quarter Financial ResultsApril 30, 2024 | marketbeat.comBioventus (BVS) Set to Announce Quarterly Earnings on TuesdayBioventus (NYSE:BVS) will be releasing earnings before the market opens on Tuesday, May 7, Zacks reports. (Register for Conference Call at http://mmm.wallstreethorizon.com/u.asp?u=591097)April 29, 2024 | globenewswire.comBioventus to Report First Quarter of Fiscal Year 2024 Financial Results on May 7, 2024April 17, 2024 | investing.comBioventus CFO sells shares worth $19,000April 16, 2024 | insidertrades.comInsider Selling: Bioventus Inc. (NYSE:BVS) SVP Sells 3,054 Shares of StockApril 15, 2024 | marketbeat.comBioventus Inc. (NYSE:BVS) SVP Anthony D'adamio Sells 3,054 SharesBioventus Inc. (NYSE:BVS - Get Free Report) SVP Anthony D'adamio sold 3,054 shares of the firm's stock in a transaction on Thursday, April 11th. The stock was sold at an average price of $4.75, for a total value of $14,506.50. Following the completion of the transaction, the senior vice president now directly owns 58,242 shares of the company's stock, valued at $276,649.50. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available through the SEC website.April 6, 2024 | marketbeat.comKent Lake Capital LLC Sells 502,288 Shares of Bioventus Inc. (NYSE:BVS)Kent Lake Capital LLC cut its holdings in Bioventus Inc. (NYSE:BVS - Free Report) by 48.5% during the fourth quarter, according to its most recent Form 13F filing with the SEC. The firm owned 532,880 shares of the company's stock after selling 502,288 shares during the period. Kent Lake Capital LLCMarch 26, 2024 | insidertrades.comBioventus Inc. (NYSE:BVS) CFO Sells $29,865.99 in StockMarch 21, 2024 | insidertrades.comBioventus Inc. (NYSE:BVS) SVP Anthony D'adamio Sells 3,125 SharesMarch 20, 2024 | marketbeat.comInsider Selling: Bioventus Inc. (NYSE:BVS) SVP Sells 3,125 Shares of StockBioventus Inc. (NYSE:BVS - Get Free Report) SVP Anthony D'adamio sold 3,125 shares of the company's stock in a transaction on Friday, March 15th. The shares were sold at an average price of $5.46, for a total value of $17,062.50. Following the completion of the transaction, the senior vice president now owns 51,371 shares of the company's stock, valued at approximately $280,485.66. The sale was disclosed in a filing with the SEC, which is available through the SEC website.March 13, 2024 | bizjournals.comDurham public company resets priorities under new CEOMarch 13, 2024 | finance.yahoo.comBioventus Inc. (NASDAQ:BVS) Q4 2023 Earnings Call TranscriptMarch 12, 2024 | markets.businessinsider.comWhat Wall Street expects from Repro Medical System's earningsMarch 12, 2024 | msn.comBioventus Non-GAAP EPS of $0.07 beats by $0.05, revenue of $135.42M beats by $11.46MMarch 12, 2024 | finance.yahoo.comBioventus Inc (BVS) Reports Growth in Q4 Sales and Adjusted EBITDA, Provides Optimistic 2024 ...March 12, 2024 | globenewswire.comBioventus Announces Fourth Quarter and Full Year 2023 Financial ResultsMarch 12, 2024 | nz.finance.yahoo.comBioventus Inc. (BVS) stock price, news, quote & history – Yahoo FinanceMarch 11, 2024 | benzinga.comA Preview Of Bioventus's EarningsMarch 4, 2024 | globenewswire.comBioventus to Report Fourth Quarter of Fiscal Year 2023 Financial Results on March 12, 2024February 15, 2024 | wsj.comBioventus Inc. Cl AJanuary 24, 2024 | seekingalpha.comBioventus: Bullish On Path To ProfitabilityJanuary 19, 2024 | finanznachrichten.deBioventus, Inc.: Bioventus Enters into an Amendment with its Credit Agreement Lenders to Enhance Financial and Operational FlexibilityJanuary 12, 2024 | finance.yahoo.comBioventus Announces Inducement Equity to President and Chief Executive Officer Robert ClaypooleDecember 27, 2023 | businesswire.comBIOVENTUS ALERT: Bragar Eagel & Squire, P.C. is Investigating Bioventus Inc. on Behalf of Long-Term Stockholders and Encourages Investors to Contact the FirmDecember 21, 2023 | benzinga.comBioventus Stock (NASDAQ:BVS) Dividends: History, Yield and DatesDecember 20, 2023 | bizjournals.comDurham public company names new CEO at critical junctureDecember 19, 2023 | finance.yahoo.comBioventus Names Robert Claypoole as President and Chief Executive OfficerDecember 16, 2023 | msn.comBioventus Inc - (BVS) Price Target Increased by 34.58% to 6.63December 8, 2023 | msn.comCanaccord Genuity Upgrades Bioventus Inc - (BVS)November 27, 2023 | msn.comBioventus Inc - (BVS) Price Target Increased by 7.33% to 4.93November 14, 2023 | morningstar.comBioventus Inc Class ANovember 12, 2023 | finance.yahoo.comBioventus Inc. (NASDAQ:BVS) Q3 2023 Earnings Call TranscriptNovember 7, 2023 | finanznachrichten.deBioventus, Inc.: Bioventus Reports Third Quarter Financial Results; Raises Full Year 2023 Financial GuidanceNovember 7, 2023 | msn.comBioventus Non-GAAP EPS of $0.05 beats by $0.07, revenue of $120.8M beats by $1.8MNovember 7, 2023 | finance.yahoo.comBioventus Reports Third Quarter Financial Results; Raises Full Year 2023 Financial GuidanceNovember 7, 2023 | finance.yahoo.comBioventus Inc (BVS) Reports Q3 2023 Financial Results, Raises Full Year 2023 Financial GuidanceNovember 5, 2023 | morningstar.comBioventus Inc Class A BVSOctober 31, 2023 | finance.yahoo.comBioventus to Report Third Quarter of Fiscal Year 2023 Financial Results on November 7, 2023October 25, 2023 | finance.yahoo.comBioventus (BVS) to Report Q3 Earnings: What's in the Cards?September 28, 2023 | finance.yahoo.com3 Value Medical Stocks to Buy for Safety Amid Market Volatility Get Bioventus News Delivered to You Automatically Sign up to receive the latest news and ratings for BVS and its competitors with MarketBeat's FREE daily newsletter. Email Address This military-backed stock “owns” AI market (Ad)The AI boom is just getting started. And the real wealth has still to be made… You must read this new presentation from Porter Stansberry. BVS Media Mentions By Week BVS Media SentimentLearn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. BVS News Sentiment▼0.100.76▲Average Medical News Sentiment BVS News CoverageLearn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. BVS Articles This Week▼11▲BVS Articles Average Week Get Bioventus News Delivered to You Automatically Sign up to receive the latest news and ratings for BVS and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies: UFP Technologies News LeMaitre Vascular News Alphatec News AtriCure News MiMedx Group News Artivion News Perspective Therapeutics News Silk Road Medical News Atrion News OrthoPediatrics News Headlines Tools: Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NYSE:BVS) was last updated on 6/2/2024 by MarketBeat.com Staff From Our PartnersTrump’s Gift Could Unleash $51 Billion in New WealthWealthpin ProThe #1 Crypto That You Don’t Own… YetCrypto 101 MediaBiden replacement revealed?Paradigm PressBiden Nomination CANCELED?The Freeport SocietyWarren Buffett, Jeff Bezos, Michael Bloomberg, & 48 Members of Congress Are Buying ONE Sector…InvestorPlaceNvidia has Apple and Microsoft within striking rangeWeiss RatingsDon’t buy a single NVIDIA share before you see this...Behind the MarketsExposed: 10 CENT Crypto to Explode May 20th?True Market Insiders Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Bioventus Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
